Idera Pharmaceuticals (IDRA) Stock: Climbing on Positive Data

By |December 7th, 2015|

Idera Pharmaceuticals Inc (NASDAQ: IDRA)

Idera Pharmaceuticals had an incredible day in the market on Monday as the result of solid data that was presented over the weekend. The data surrounded the company’s lead candidate IMO-8400. Today, we’ll discuss what we saw from the clinical trial of IMO-8400, how the market reacted to the news […]